India Coronavirus Cases: The national recovery rate is 92.79 per cent. (File)
India's COVID-19 caseload went past 86.83 lakh, while the number of people who have recuperated from the disease surged to 80,66,502, pushing the national recovery rate to 92.79 per cent, according to the Union Health Ministry's data.
With 47,905 more people testing positive for coronavirus in a span of 24 hours, the infection tally mounted to 86,83,917, while the deaths rose to 1,28,121 after 550 new fatalities were reported, the data showed.
Meanwhile, any COVID-19 survivors are likely to be at greater risk of developing mental illness, psychiatrists said on Monday, after a large study found 20% of those infected with the coronavirus are diagnosed with a psychiatric disorder within 90 days.
Anxiety, depression and insomnia were most common among recovered COVID-19 patients in the study who developed mental health problems. The researchers from Britain's Oxford University also found significantly higher risks of dementia, a brain impairment condition.
"People have been worried that COVID-19 survivors will be at greater risk of mental health problems, and our findings ... show this to be likely," said Paul Harrison, a professor of psychiatry at Oxford.
Here are the LIVE updates on Coronavirus Cases:
Serum Institute of India & ICMR, announce completion of enrolment of phase 3 clinical trials for COVISHIELD in India. ICMR & SII have further collaborated for clinical development of COVOVAX (Novavax) developed by Novavax, USA & upscaled by SII: Serum Institute of India
With 47,905 new COVID-19 infections, India's total cases surge to 86,83,917. With 550 new deaths, count mounts to 1,28,121
Total active cases are 4,89,294 after a decrease of 5,363 in the last 24 hrs.
Total cured cases are 80,66,502 with 52,718 new discharges in the last 24 hours.
A total of 12,19,62,509 samples tested for COVID-19 up to 11th November, of these 11,93,358 samples were tested yesterday: Indian Council of Medical Research
Coronavirus LIVE Updates: Restaurants, Gyms, Hotels Carry Highest Covid Superspreader Risk: Study
The reopening of restaurants, gyms and hotels carries the highest danger of spreading Covid-19, according to a study that used mobile phone data from 98 million people to model the risks of infection at different locations.
Researchers at Stanford University and Northwestern University used data collected between March and May in cities across the U.S. to map the movement of people. They looked at where they went, how long they stayed, how many others were there and what neighborhoods they were visiting from. They then combined that information with data on the number of cases and how the virus spreads to create infection models.
Jharkhand Reports 284 New COVID-19 Cases, 3 Fatalities
Jharkhand's COVID-19 tally rose to 1,05,224 on Thursday as 284 more people tested positive for the infection, a health official said.
Three fresh fatalities pushed the state's coronavirus death count to 913, he said.
Ranchi district reported the highest number of new cases at 78, followed by Bokaro (40), Dhanbad (37) and East Singhbhum (29), the official said.
One fresh fatality each was reported in East Singhbhum, Bokaro and Ranchi districts, he said.
The state now has 4,009 active coronavirus cases, while 1,00,302 people have been cured of the disease so far, the official said.
Jharkhand has tested 25,320 samples for COVID-19 on Wednesday, he added.
Moderna Expecting To Announce Results Of COVID-19 Vaccine By End Of Month
Moderna expects to have an announcement on the efficacy of its COVID-19 vaccine after it finished accumulating data for a first analysis of the vaccine, the company said in a statement on Wednesday.
Moderna is conducting a clinical trial of about 30,000 participants, with half of the participants receiving the vaccine and the other half receiving a placebo, which is a shot of saline that does not seem to have any effect, reported CNN.
In order for the vaccine to be considered for authorization by the US Food and Drug Administration (FDA), at least 53 study participants needed to become ill with COVID-19.
The trial hit the 53-mark Wednesday, but Moderna doesn't know if the participants who became ill received the vaccine or the placebo. The company is now preparing data to send to the trial's Data and Safety Monitoring Board, an independent panel of experts.
If a statistically significant number of participants received the placebo, that would mean that the vaccine is effective against the virus.
Mainland China Reports 15 New COVID-19 Cases Vs 17 A Day Earlier
Mainland China reported 15 new COVID-19 cases for Nov. 11, down from 17 cases a day earlier, the country's national health authority said on Thursday.
The National Health Commission said in a statement that one of the new cases was a local infection in Tianjin. The remaining 14 cases were imported infections that originated from overseas, the commission said.
The total number of new asymptomatic cases fell to six from 15 reported a day earlier. China does not count symptomless patients as confirmed COVID-19 cases.
The total number of confirmed COVID-19 cases in mainland China to date now stands at 86,299, while the death toll remained unchanged at 4,634.
Coronavirus Live Updates: US Hits New All-Time High In Daily COVID-19 Cases
The United States hit a record-setting 136,325 new daily cases of the novel coronavirus (COVID-19) disease, the latest data from Johns Hopkins University revealed.
The United States has reported more than 10.3 million cases of COVID-19 and more than 240,800 deaths caused by the disease, data showed on Wednesday.
The third wave of COVID-19 infections is underway in the United States as winter approaches.
Numerous US states are facing strained resources at medical facilities, such as shortages of medical personnel and hospital beds, forcing additional lockdowns in the communities considered hotspots.
The Trump administration has vowed to have a vaccine ready to be distributed by the end of the year.
Russia Says Sputnik V Vaccine 92% Effective Against Coronavirus
Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.
The initial results are only the second to be published from a late-stage human trial in the global race to produce a vaccine that could halt a pandemic that has killed more than 1.2 million people and ravaged the world economy.
Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.
Brazil Allows Resumption Of Chinese Coronavirus Vaccine Trial
Brazil's health regulator Anvisa on Wednesday (local time) announced the resumption of clinical trials of China''s Sinovac COVID-19 vaccine.
Quoting the latest official statement issued by Anvisa, Anadolu agency's said, "After evaluating the new data presented by the sponsor ... Anvisa understands that it has sufficient reasons to allow the resumption of vaccination."
"It is important to clarify that a suspension does not necessarily mean that the product under investigation is not of quality, safety or efficacy...The suspension and resumption of clinical studies are common events in clinical research and all studies aimed at registering medicines that are authorized in the country are previously evaluated by ANVISA in order to preserve safety for the study volunteers," the statement further read.
This comes days after the trial was suspended following " a severe incident".
Odisha reports 1,220 new COVID-19 cases, 15 fresh fatalities
Odisha's COVID-19 tally rose to 3,05,000 on Wednesday as 1,220 more people tested positive for the infection, a health official said. Fifteen fresh fatalities pushed the coronavirus deaths in the state to 1,469, he said.
At least 1,340 more patients were cured of the disease during the day, taking the total number of recoveries to 2,92,477, which is 95.89 per cent of the state''s caseload, the official said.
Cyprus announces local lockdowns to curb virus spike
Cyprus on Wednesday announced partial lockdowns in its virus hotspots on the Mediterranean coast and other measures in an effort to curb a spike in coronavirus cases.
The resort towns of Limassol and Paphos on the south coast are to go into partial lockdown from Thursday until the end of November.
Health Minister said that travel into or out of the towns would be banned, and a curfew in force from 8 pm to 5 am.
China reports 15 new COVID-19 cases
China reported 15 new COVID-19 cases for November 11, down from 17 cases a day earlier, the country's national health authority said on Thursday. The National Health Commission said in a statement that one of the new cases was a local infection in Tianjin.
The remaining 14 cases were imported infections that originated from overseas, the commission said. The total number of new asymptomatic cases fell to six from 15 reported a day earlier
Watch Live News:
